Analysis of KRAS gene mutation associated with Helicobacter pylori infection in patients with gastric cancer

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 270

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-22-5_010

تاریخ نمایه سازی: 20 مهر 1398

چکیده مقاله:

Objective(s): KRAS proto-oncogene mutation can be considered a diagnostic factor for treating various malignancies. Helicobacter pylori infection, a risk factor for stomach cancer, may cause DNA damage and genetic changes. The aim of the current study was to assess the association of gastric cancer and KRAS mutation, demographic factors, and H. pylori infection.Materials and Methods: DNA was extracted from a total of 140 FFPE gastric cancer tissue samples. detection of KRAS mutation (codons 12 and 13) in tumors was performed by PCR amplification, followed by gel electrophoresis and DNA sequencing. PCR diagnosed any H. pylori infection.Results: KRAS mutation was detected in 6 of the 140 (4.2%) gastric cancer tissue samples. 18 samples (12.8%), all of which were male (P<0.05), tested positive for H. pylori infection. KRAS mutations were present in 22.2% (4/18) of the samples with H. pylori infection (P<0.05). The mean age of patients was 62.25±12.61 years (range: 30–93 years). A male predominance (2.5 to 1) was reported in the gastric cancers, and at diagnosis, women were significantly younger than men (P=0.004). No association was observed between age or gender and KRAS mutation. Neither was one found between age and H. pylori infection. Tumors from H. pylori+ subjects were significantly more likely to have KRAS mutation than tumors from H. pylori- subjects (OR=17.1).Conclusion: The data suggest that H. pylori infection when compared with the absence of H. pylori infection, is associated with a higher prevalence of KRAS mutation in gastric cancer.

نویسندگان

Raheleh Jabini

Biotechnology Research Center, Pharmaceutical technology institute, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed Ahmad Eghbali

Gastroenterology and Hepatology Specialist, Mashhad, Iran

Hosein Ayatolahi

Pathology Department of Hematology and Blood Banking, Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Sheikhi

Pathology Department of Hematology and Blood Banking, Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Jiang B, Li S, Jiang Z, Shao P. Gastric cancer ...
  • Shibata A, Parsonnet J, Longacre TA, Garcia MI, Puligandla B, ...
  • Amoori N, Mahdavi S, Enayatrad M. Epidemiology and trend of ...
  • Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, ...
  • Do H, Krypuy M, Mitchell PL, Fox SB, Dobrovic A. ...
  • Hamzehzadeh L, khadangi F, Ghayoor Karimiani E, Pasdar A, Kerachian ...
  • Castagnola P, Giaretti W. Mutant KRAS, chromosomal instability and prognosis ...
  • Furukawa T, Sunamura M, Horii A. Molecular mechanisms of pancreatic ...
  • Karachaliou N, Mayo C, Costa C, Magrí I, Gimenez-Capitan A, ...
  • Sepulveda AR. Helicobacter, inflammation, and gastric cancer. Curr Pathobiol Rep ...
  • Saghier AA, Kabanja JH, Afreen S, Sagar M. Gastric cancer: ...
  • Rugge M, Fassan M,Graham DY. Epidemiology of gastric cancer. In: ...
  • Zarea K, Beiranvand S, Ghanbari S,Tuvesson H. Incidence of gastrointestinal ...
  • Nardone G. Molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther ...
  • Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A,Fleig ...
  • Chen C, Köberle B, Kaufmann AM, Albers AE. A quest ...
  • Jabini R, Moradi A, Afsharnezhad S, Ayatollahi H, Behravan J, ...
  • Ebrahimian M, Taghavi S, Ghoreishi M, Sedghi S, Farzad S ...
  • Farzanehfar M, Vossoughinia H, Jabini R, Tavassoli A, Saadatnia H, ...
  • Fernández-Medarde A, Santos E. Ras in cancer and developmental diseases. ...
  • Vakiani E, Solit DB. KRAS and BRAF: drug targets and ...
  • Amado R G, Wolf M, Peeters M, Van Cutsem E, ...
  • Lievre A, Bachet JB, Le Corre D, Boige V, Landi ...
  • Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a ...
  • Khadangi F, Yassi M, kerachian MA. Diagnostic accuracy of PCR-based ...
  • Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. ...
  • Towensend CMJR,  Beauchamp RD. Stomach. In: Townsend CM, editor. Sabistone ...
  • Bos JL, Vries MVd, Marshall CJ, Veeneman GH, Van Boom ...
  • Victor T, Du Toit R, Jordaan AM, Bester AJ, Van ...
  • Saxena A, Shukla SK, Prasad KN, Ghoshal UC. Analysis of ...
  • Mita H, Toyota M, Aoki F, Akashi H, Maruyama R, ...
  • Craanen ME, Blok P, Top B, Boerrigter L, Dekker W, ...
  • Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, ...
  • Miki H, Ohmori M, Perantoni AO, Enomoto T. K-ras activation ...
  • Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, ...
  • Nejat M, Rabbani B. An overview of mutation detection methods ...
  • Sasao S, Hiyama T, Tanaka S, Yoshihara M, Yasui W, ...
  • Zhu Y, Zhou X, Wu J, Su J, Zhang G. ...
  • Agah S, Khedmat H, Ghamar-Chehred M E, Hadi R, Aghaei ...
  • Chey WD, Lontiadis GI, Howden CW, Moss SF. ACG Clinical ...
  • Mastromatteo P, Correnti M, Cavazza ME, Perrone M, Tombazzi C, ...
  • Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, ...
  • Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, ...
  • نمایش کامل مراجع